CLDX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Celldex Therapeutics Inc

Watchlist Manager

Watchlist

Price: 33.78 USD 2.43% Market Closed

Market Cap: $2.7B

	Celldex Therapeutics Inc NASDAQ:CLDX	US
T	TAL Education Group SWB:IZZ	CN
A	Assystem SA F:BZ1	FR

Profitability Summary

Celldex Therapeutics Inc's profitability score is 4/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-35.688%

Negative 3Y Average Operating Margin

-7.449%

Declining Operating Margin

-3.951% > -35.688%

Negative Net Margin

-32.754%

Negative 3Y Average Net Margin

-6.693%

Declining Net Margin

-3.766% > -32.754%

Negative Free Cash Flow Margin

-26.126%

Negative 3Y Average Free Cash Flow Margin

-5.597%

Declining Free Cash Flow Margin

-3.480% > -26.126%

Negative ROE

-49%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-396%

Declining ROIC

-292% > -551%

View All

Hide

Collapse

4 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.